Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.

Metadata

Authors/Creators:
Dates:
  • Published: April 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Funding Information:
FunderGrant number
NIHR National Inst Health ResearchDRF-2014-07-155
Depositing User: Symplectic Publications
Date Deposited: 03 Apr 2019 16:37
Last Modified: 03 Apr 2019 16:37
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kew105.001
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)